dRx Capital AG is a venture capital firm founded in 2015 that serves as the investment arm of QUALCOMM Incorporated and Novartis AG. Based in the United States, dRx Capital specializes in early-stage investments in the pharmaceutical, mobile, IT, and digital medicine sectors. The firm focuses on supporting entrepreneurs who are transforming healthcare through data and digital technology, with a particular emphasis on areas such as artificial intelligence, machine learning, big data, research and development optimization, patient care, and the pharmaceutical supply chain. dRx Capital typically invests between $5 million and $100 million in innovative technology platforms aimed at improving access to healthcare and enhancing the practice of medicine.
Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.